| Drug Type Small molecule drug, Diagnostic radiopharmaceuticals | 
| Synonyms- | 
| Target | 
| Action modulators, enhancers | 
| Mechanism ESRRG modulators(estrogen related receptor gamma modulators), PET imaging(Positron-emission tomography enhancers) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Inflammation | Preclinical | United States  | 27 Sep 2024 | |
| Inflammation | Preclinical | United States  | 27 Sep 2024 | 





